UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.85 +0.83 (+1.06%) GOLD FUTURES
2,392.90 +33.00 (+1.40%) DOW
39,908.07 +349.96 (+0.88%) Bitcoin GBP
52,036.12 +3,498.01 (+7.21%)
NVCR May 2024 25.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:53AM EDT. Market open.
| Previous close | 0.1500 |
| Open | 0.0600 |
| Bid | 0.0000 |
| Ask | 0.1500 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0600 - 0.0600 |
| Contract range | N/A |
| Volume | |
| Open interest | 100 |
Insider MonkeyNovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beats earnings expectations. Reported EPS is $-0.36134, expectations were $-0.43. NVCR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]
GuruFocus.comNovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
Comprehensive Analysis of NovoCure's First Quarter Financial Performance
ZacksNovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
NovoCure (NVCR) delivered earnings and revenue surprises of 16.28% and 5.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.